Share-based Payment Arrangement, Expense of CLOVER HEALTH INVESTMENTS, CORP. /DE from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $24,919,000, a 16% decline year-over-year.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $103,657,000, a 9.3% decline year-over-year.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE annual Share-based Payment Arrangement, Expense for 2025 was $103,657,000, a 9.3% decline from 2024.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE annual Share-based Payment Arrangement, Expense for 2024 was $114,331,000, a 19% decline from 2023.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE annual Share-based Payment Arrangement, Expense for 2023 was $140,931,000, a 14% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $103,657,000 $24,919,000 -$4,726,000 -16% 01 Oct 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $108,383,000 $26,106,000 -$1,882,000 -6.7% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $110,265,000 $26,195,000 -$1,705,000 -6.1% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $111,970,000 $26,437,000 -$2,361,000 -8.2% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $114,331,000 $29,645,000 -$3,491,000 -11% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $117,822,000 $27,988,000 -$5,082,000 -15% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $122,904,000 $27,900,000 -$8,208,000 -23% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $131,112,000 $28,798,000 -$9,819,000 -25% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $140,931,000 $33,136,000 -$5,961,000 -15% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
Q3 2023 $146,892,000 $33,070,000 -$9,571,000 -22% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $156,463,000 $36,108,000 -$5,819,000 -14% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $162,282,000 $38,617,000 -$2,023,000 -5% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $164,305,000 $39,097,000 +$7,916,000 +25% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $156,389,000 $42,641,000 -$4,162,000 -8.9% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $160,551,000 $41,927,000 -$1,099,000 -2.6% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $161,650,000 $40,640,000 -$2,073,000 -4.9% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $163,723,000 $31,181,000 +$29,051,000 +1364% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $134,672,000 $46,803,000 +$45,303,000 +3020% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $89,369,000 $43,026,000 +$41,555,000 +2825% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $47,814,000 $42,713,000 +$40,736,000 +2060% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $7,078,000 $2,130,000 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $1,500,000 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $1,471,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $1,977,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1

CLOVER HEALTH INVESTMENTS, CORP. /DE Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $103,657,000 -$10,674,000 -9.3% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $114,331,000 -$26,600,000 -19% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $140,931,000 -$23,374,000 -14% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
2022 $164,305,000 +$582,000 +0.36% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $163,723,000 +$156,645,000 +2213% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $7,078,000 +$3,777,000 +114% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $3,301,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.